Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

News | FFR Technologies

November 8, 2017 — Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their ...

Home November 08, 2017
Home
News | Heart Valve Technology

November 8, 2017 —  Medtronic plc recently presented new clinical research to support the positive clinical performance ...

Home November 08, 2017
Home
Videos | Heart Valve Technology

Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...

Home November 08, 2017
Home
Videos | Heart Valve Technology

Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the ...

Home November 08, 2017
Home
Videos | Stents Bioresorbable

A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian ...

Home November 07, 2017
Home
Harpoon Mitral Valve Repair System data reported at TCT 2017
Feature | Heart Valve Technology

November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and can ...

Home November 07, 2017
Home
Videos | Heart Valve Technology

Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of ...

Home November 07, 2017
Home
News | Heart Valve Technology

November 7, 2017 — Medtronic plc recently presented positive data for its self-expanding Intrepid transcatheter mitral ...

Home November 07, 2017
Home
News | Heart Valve Technology

November 7, 2017 — A new study has found that a pioneering device to repair heart valves is safe and effective, and can ...

Home November 07, 2017
Home
News | Dave Fornell

November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different ...

Home November 06, 2017
Home
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab

November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found no ...

Home November 06, 2017
Home
News | Heart Valve Technology

November 6, 2017 — One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System ...

Home November 06, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 6, 2017 —  The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months ...

Home November 06, 2017
Home
News | FFR Technologies

November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 6, 2017 — Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...

Home November 06, 2017
Home
Subscribe Now